HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 729055Generated: October 26, 2026
7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid → Norfloxacin
https://huagongshe.com/reaction/729055
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | HCID 483169 | — |
| Reactant | Tetrabutylammonium Fluoride Trihydrate | HCID 11726816 | — |
| Reactant | Tert-butyl-dimethyl-piperazin-1-ylsilane | HCID 19434780 | — |
| Solvent | Pyridine | HCID 1049 | — |
| Product | Norfloxacin | HCID 4539 | 90% |
Reaction Steps
0.5 g (1.85 mmol) of 1-ethyl-6-fluoro-7-chloro-4-oxo1,4-dihydro-quinoline-3-carboxylic acid (II, R1 : ethyl; X: chloro) and 1.1 g (5.5 mmol) of 1-(t-butyldimethylsilyl) piperazine (R2 : hydrogen, R3 and R4 : methyl; R5 : t-butyl) are added to 5 ml of pyridine and then heated at 60° C. A solution of 1.73 g (5.5 mmol) of tetrabutylammonium fluoride trihydrate in 5 ml of pyridine is added dropwise to the reaction mixture. After completion of addition, the reaction mixture is heated at 80° C. for 2 hours and then distilled under reduced pressure (10 mmHg, 60° C.). The residue is added with water and then stirred to afford a crystal. After filtering and drying, 0.50 g of a solid product is obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05051505 |
|---|
| Source dataset | uspto-grants-1991_09 |
|---|
| ORD ID | ord-89447a34551745f9b5e2b2b7bd474a35 |
|---|
| Source note | uspto-grants-1991_09 |
|---|